E
Eric J. Topol
Researcher at Scripps Health
Publications - 1406
Citations - 162373
Eric J. Topol is an academic researcher from Scripps Health. The author has contributed to research in topics: Myocardial infarction & Angioplasty. The author has an hindex of 193, co-authored 1373 publications receiving 151025 citations. Previous affiliations of Eric J. Topol include Loyola University Chicago & Cleveland Clinic.
Papers
More filters
Journal ArticleDOI
Impact of Diabetes Mellitus on Percutaneous Revascularization (CAVEAT-I)
Glenn N. Levine,Alice K. Jacobs,Gordon Keeler,Patrick L. Whitlow,Lisa G. Berdan,Fred Leya,Eric J. Topol,Robert M. Califf +7 more
TL;DR: The higher restenosis and repeat revascularization rates and the smaller minimum luminal diameter at follow-up in diabetic patients suggest that atherectomy may provide only modest benefit for these patients.
Journal ArticleDOI
Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial: one-year follow-up of patients without ST-segment elevation. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) II Investigators.
Yuling Fu,Wei-Ching Chang,Daniel B. Mark,Robert M. Califf,Brian Mackenzie,Christopher B. Granger,Eric J. Topol,Mark A. Hlatky,Paul W. Armstrong +8 more
TL;DR: Whereas more frequent coronary interventions were not associated with reduced recurrent MI or death among MI patients without ST elevation, they may favorably affect outcomes in patients with unstable angina.
Journal ArticleDOI
Myocardial infarction with minimal coronary atherosclerosis in the era of thrombolytic reperfusion
Dean J. Kereiakes,Eric J. Topol,Barry S. George,Richard S. Stack,Charles W. Abbottsmith,Stephen G. Ellis,Richard J. Candela,Lynn Harrelson,Linda H. Martin,Robert M. Califf +9 more
TL;DR: New strategies are needed to prevent coronary rethrombosis in patients with minimal atherosclerosis after thrombolytic therapy for acute myocardial infarction.
Journal ArticleDOI
Prophylactic lidocaine use in acute myocardial infarction: Incidence and outcomes from two international trials ☆ ☆☆ ★ ★★
John H. Alexander,Christopher B. Granger,Zygmunt Sadowski,Zygmunt Sadowski,Philip E. Aylward,Harvey D. White,Harvey D. White,Trevor D. Thompson,Trevor D. Thompson,Robert M. Califf,Robert M. Califf,Eric J. Topol,Eric J. Topol +12 more
TL;DR: In this paper, the authors determined the frequency and effect of prophylactic lidocaine on clinical outcomes with its use in the thrombolytic era and found that the use may not be associated with increased mortality rates.
Journal ArticleDOI
Digital medicine, on its way to being just plain medicine
TL;DR: The vision for npj Digital Medicine is to provide a reliable, evidence-based forum for all clinicians, researchers, and even patients, curious about how digital technologies can transform every aspect of health management and care.